Skip to main content
SpringerLink
Log in

The Ideal Eight-Step Urologic Diet and Lifestyle Program: Heart Health = Urologic Health

  • Chapter
  • First Online:
Book cover Complementary & Alternative Medicine for Prostate and Urologic Health

  • 921 Accesses

Abstract

The primary cause of mortality in the USA and in most developed countries is cardiovascular disease (CVD), and it is the primary cause of death in the largest clinical trials ever conducted for preventing a variety of urologic health conditions. The overall risk of mortality needs to be placed into perspective. It does not serve to belittle the seriousness of other common and not so common urologic health conditions; rather, it serves as an ideal nexus for healthcare professional and patient educational purposes. Heart-healthy recommendations have been tantamount to overall urologic health recommendations because there are simplistic correlations between heart health and urologic-specific diseases. Healthcare professionals working in the field of urology need to motivate and provide a simplistic and realistic set of diet and lifestyle recommendations to patients in order to impact the more important statistic of urologic health known as “all-cause morbidity and mortality.” A list of eight heart-healthy recommendations is provided in this chapter to assist the clinician and patient in their discussions of practical, logical, and realistic changes that may not only be accomplished in a short period of time but should provide at least some type of tangible overall benefit for the individual concerned about her or his urologic health.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, D Simone G, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation. 2010;121:e46–215.

    PubMed  Google Scholar 

  2. World Heart Federation web site. Available at: http://www.world-heart-federation.org. Accessed 20 March 2010.

  3. Eyre H, Kahn R, Robertson RM, Clark NG, Doyle C, Hong Y, American Cancer Society; American Diabetes Association, and the American Heart Association, et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation. 2004;109:3244–55.

    PubMed  Google Scholar 

  4. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GS, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215–24.

    PubMed  CAS  Google Scholar 

  5. Scardino PT. The prevention of prostate cancer-The dilemma continues. N Engl J Med. 2003;349:297–9.

    PubMed  Google Scholar 

  6. Kaplan SA, Roehrborn CG, Meehan AG, Liu KS, Carides AD, Binkowitz BS, et al. PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer. Urology. 2009;73:935–9.

    PubMed  Google Scholar 

  7. Lippman SM, Klein EA, Goodman PJ, Lucia MA, Thompson IM, Ford LG, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009;301:39–51.

    PubMed  CAS  Google Scholar 

  8. Nash IS, Mosca L, Blumenthal RS, Davidson MH, Smith SC, Paternak RC. Contemporary awareness and understanding of cholesterol as a risk factor: Results of an American Heart Association National Survey. Arch Intern Med. 2003;163:1597–600.

    PubMed  Google Scholar 

  9. Hickey A, O’Hanlon A, McGee H, Donnellan C, Shelley E, Horgan F, et al. Stroke awareness in the general population: knowledge of stroke risk factors and warning signs in older adults. BMC Geriatr. 2009;9:35.

    PubMed  Google Scholar 

  10. Jones SP, Jenkinson AJ, Leathley MJ, Watkins CL. Stroke knowledge and awareness: an integrative review of the evidence. Age Ageing. 2010;39:11–22.

    PubMed  Google Scholar 

  11. Reiner Z, Sonicki Z, Tedeschi-Reiner E. The perception and knowledge of cardiovascular risk factors among medical students. Croat Med J. 2012;53: 278–84.

    PubMed  Google Scholar 

  12. Rogers VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation. 2012;125:e2–220.

    Google Scholar 

  13. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–98.

    Google Scholar 

  14. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation. 2004;110:227–39.

    PubMed  Google Scholar 

  15. Ketchandji M, Kuo YF, Shahinian VB, Goodwin JS. Cause of death in older men after the diagnosis of prostate cancer. J Am Geriatr Soc. 2009;57:24–30.

    PubMed  Google Scholar 

  16. Centers for Disease Control and Prevention. Prevalence of abnormal lipid levels among youths-United States 1999–2006. MMWR Morb Mortal Wkly Rep. 2010;59:29–33.

    Google Scholar 

  17. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107:363–9.

    PubMed  Google Scholar 

  18. Chang ST, Chu CM, Hsu JT, Hsiao JF, Chung CM, Ho C, et al. Independent determinants of coronary artery disease in erectile dysfunction patients. J Sex Med. 2010;7(4 Pt 1):1478–87.

    PubMed  CAS  Google Scholar 

  19. Kraus WE, Houmard JA, Duscha BD, Knetzger KJ, Wharton MB, McCartney JS, et al. Effects of the amount and intensity of exercise on plasma lipoproteins. N Engl J Med. 2002;347:1483–92.

    PubMed  CAS  Google Scholar 

  20. Hammarsten J, Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol. 2001;39:151–8.

    PubMed  CAS  Google Scholar 

  21. Mondul AM, Weinstein SJ, Virtamo J, Albanes D. Serum total and HDL cholesterol and risk of prostate cancer. Cancer Causes Control. 2011;22:1545–52.

    PubMed  Google Scholar 

  22. Van Hemelrijck M, Garmo H, Holmberg L, Walldius G, Jungner I, Hammar N, et al. Prostate cancer risk in the Swedish AMORIS study: the interplay among triglycerides, total cholesterol, and glucose. Cancer. 2011;117:2086–95.

    PubMed  Google Scholar 

  23. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee, et al. Hypertension. 2003;42:1206–52.

    PubMed  CAS  Google Scholar 

  24. Whelton SP, Chin A, Xin X, He J. Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Ann Intern Med. 2002;136:493–503.

    PubMed  Google Scholar 

  25. Ponholzer A, Temmi C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol. 2005;47:80–5.

    PubMed  Google Scholar 

  26. Chong C, Fong L, Lai R, Lau WK, Hartmann M, Chia SE. The prevalence of lower urinary tract symptoms and treatment-seeking behaviour in males over 40 years in Singapore: a community-based study. Prostate Cancer Prostatic Dis. 2012;15: 273–7.

    PubMed  CAS  Google Scholar 

  27. Hillborn M, Saloheimo P, Juvela S. Alcohol consumption, blood pressure, and the risk of stroke. Curr Hypertens Rep. 2011;13:208–13.

    Google Scholar 

  28. Strijk JE, Proper KI, Klaver L, van der Beek AJ, van Mechelen W. Associations between VO2max and vitality in older workers: a cross-sectional study. BMC Public Health. 2010;10:684.

    PubMed  Google Scholar 

  29. Blair SN, Morris JN. Healthy hearts- and the universal benefits of being physically active: physical activity and health. Ann Epidemiol. 2009;19:253–6.

    PubMed  Google Scholar 

  30. Baguet JP. Out-of-office blood pressure: from measurement to control. Integr Blood Press Control. 2012;5:27–34.

    PubMed  Google Scholar 

  31. Kim WT, Yun SJ, Choi YD, Kim GY, Moon SK, Choi YH, et al. Prostate size correlates with fasting blood glucose in non-diabetic benign prostatic hyperplasia patients with normal testosterone levels. J Korean Med Sci. 2011;26:1214–8.

    PubMed  CAS  Google Scholar 

  32. Corona G, Monami M, Rastrelli G, Aversa A, Sforza A, Lenzi A, et al. Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl. 2011;34(6 Pt 1):528–40.

    PubMed  CAS  Google Scholar 

  33. Isidro ML. Sexual dysfunction in men with type 2 diabetes. Postgrad Med J. 2012;88:152–9.

    PubMed  CAS  Google Scholar 

  34. Copeland KL, Brown JS, Creasman JM, Van Den Eeden SK, Subak LL, Thom DH, et al. Diabetes mellitus and sexual function in middle-aged and older women. Obstet Gynecol. 2012;120(2 Pt 1):331–40.

    PubMed  Google Scholar 

  35. Moyad MA. Current methods used for defining, measuring, and treating obesity. Semin Urol Oncol. 2001;19:247–56.

    PubMed  CAS  Google Scholar 

  36. Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002;288:321–33.

    Google Scholar 

  37. Shike M, Latkany L, Riedel E, Fleisher M, Schatzkin A, Lanza E, et al. Lack of effect of a low-fat, high-fruit, -vegetable, and -fiber diet on serum prostate-specific antigen of men without prostate cancer: results from a randomized trial. J Clin Oncol. 2002;20:3592–8.

    PubMed  CAS  Google Scholar 

  38. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med. 2008;359:2105–20.

    PubMed  CAS  Google Scholar 

  39. Jacobs EJ, Newton CC, Wang Y, Patel AV, McCullough ML, Campbell PT, et al. Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med. 2010;170:1293–301.

    PubMed  Google Scholar 

  40. Seidell JC. Waist circumference and waist/hip ratio in relation to all-cause mortality, cancer and sleep apnea. Eur J Clin Nutr. 2010;64:35–41.

    PubMed  CAS  Google Scholar 

  41. Zhu S, Heymsfield SB, Toyoshima H, Wang Z, Pietrobelli A, Heshka S. Race-ethnicity-specific waist circumference cutoffs for identifying cardiovascular disease risk factors. Am J Clin Nutr. 2005;81:409–15.

    PubMed  CAS  Google Scholar 

  42. Chandramohan G, Kalantar-Zadeh K, Kermah D, Marie Go SC, Vaziri ND, Norris KC. Relationship between obesity and pulse pressure in children: results of the National Health and Nutrition Survey (NHANES) 1988–1994. J Am Soc Hypertens. 2012;6:277–83.

    PubMed  Google Scholar 

  43. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455–62.

    PubMed  CAS  Google Scholar 

  44. Scales Jr CD, Smith AC, Hanley JM, Saigal CS, Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62:160–5.

    PubMed  Google Scholar 

  45. Moyad MA. Obesity, interrelated mechanisms, and exposures and kidney cancer. Semin Urol Oncol. 2001;19:270–9.

    PubMed  CAS  Google Scholar 

  46. Mathew A, George PS, Ildaphonse G. Obesity and kidney cancer risk in women: a meta-analysis (1992–2008). Asian Pac J Cancer Prev. 2009;10: 471–8.

    PubMed  Google Scholar 

  47. Riedner CE, Rhoden EL, Ribeiro EP, Fuchs SC. Central obesity is an independent predictor of erectile dysfunction in older men. J Urol. 2006;176: 1519–23.

    PubMed  Google Scholar 

  48. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB. Sexual function in men older than 50 years of age: results from the Health Professionals Follow-up Study. Ann Intern Med. 2003;139:161–8.

    PubMed  Google Scholar 

  49. Walczak MK, Lokhandwala N, Hodge MB, Guay AT. Prevalence of cardiovascular risk factors in erectile dysfunction. J Gend Specif Med. 2002;5:19–24.

    PubMed  Google Scholar 

  50. Khoo J, Piantadosi C, Worthley S, Wittert GA. Effects of low-energy diet on sexual function and lower urinary tract symptoms in obese men. Int J Obes. 2010;34:1396–403.

    CAS  Google Scholar 

  51. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357:753–61.

    PubMed  CAS  Google Scholar 

  52. Sjostrom L, Narbro K, Sjostrom CD, Karason K, Larsson B, Wedel H, Swedish Obese Subjects Study, et al. N Engl J Med. 2007;357:741–52.

    PubMed  Google Scholar 

  53. Bray GA. The missing link-lose weight, live longer. N Engl J Med. 2007;357(8):818–9.

    PubMed  CAS  Google Scholar 

  54. Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA. 2012;307:56–65.

    PubMed  Google Scholar 

  55. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567–76.

    PubMed  CAS  Google Scholar 

  56. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–85.

    PubMed  CAS  Google Scholar 

  57. Giovannucci EL, Liu Y, Leitzmann MF, Stampfer MJ, Willett WC. A prospective study of physical activity and incident and fatal prostate cancer. Arch Intern Med. 2005;165:1005–10.

    PubMed  Google Scholar 

  58. Crespo CJ, Garcia-Palmieri MR, Smit E, Lee IM, McGee D, Muti P, et al. Physical activity and prostate cancer mortality in Puerto Rican men. J Phys Act Health. 2008;5:918–29.

    PubMed  Google Scholar 

  59. Moore SC, Peters TM, Ahn J, Park Y, Schatzkin A, Albanes D, et al. Physical activity in relation to total, advanced, and fatal prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:2458–66.

    PubMed  Google Scholar 

  60. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011;71:3889–95.

    PubMed  CAS  Google Scholar 

  61. Park SW, Kim TN, Nam JK, Ha HK, Shin DG, Lee W, et al. Recovery of overall exercise ability, quality of life, and continence after 12-week combined exercise intervention in elderly patients who underwent radical prostatectomy: a randomized controlled study. Urology. 2012;80:299–305.

    PubMed  Google Scholar 

  62. Leitzmann MF. Physical activity and genitourinary cancer prevention. Recent Results Cancer Res. 2011;186:43–71.

    PubMed  Google Scholar 

  63. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease in men. JAMA. 2002;288:1994–2000.

    PubMed  Google Scholar 

  64. Poehlman ET, Melby C. Resistance training and energy balance. Int J Sport Nutr. 1998;8:143–59.

    PubMed  CAS  Google Scholar 

  65. Braith RW, Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation. 2006;113:2642–50.

    PubMed  Google Scholar 

  66. Hurley BF, Roth SM. Strength training in the elderly. Sports Med. 2000;30:249–68.

    PubMed  CAS  Google Scholar 

  67. Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, et al. Physical activity and benign prostatic hyperplasia. Arch Intern Med. 1998;158:2349–56.

    PubMed  CAS  Google Scholar 

  68. Ahmed HM, Blaha MJ, Nasir K, Rivera JJ, Blumenthal RS. Effects of physical activity on cardiovascular disease. Am J Cardiol. 2012;109:288–95.

    PubMed  Google Scholar 

  69. Blake H, Mo P, Malik S, Thomas S. How effective are physical activity interventions for alleviating depressive symptoms in older people? A systematic review. Clin Rehabil. 2009;23:873–87.

    PubMed  CAS  Google Scholar 

  70. Deslandes A, Moraes H, Ferreira C, Veiga H, Silveira H, Mouta R, et al. Exercise and mental health: many reasons to move. Neuropsychobiology. 2009;59:191–8.

    PubMed  Google Scholar 

  71. Blumenthal JA, Babyak MA, Moore KA, Craighead WE, Herman S, Khatri P, et al. Effects of exercise training on older patients with major depression. Arch Intern Med. 1999;159:2349–56.

    PubMed  CAS  Google Scholar 

  72. Babyak M, Blumenthal JA, Herman S, Khatri P, Doraiswamy M, Moore K, et al. Exercise treatment for major depression: maintenance of therapeutic benefit at 10 months. Psychosom Med. 2000;62:633–8.

    PubMed  CAS  Google Scholar 

  73. Blumenthal JA, Babyak MA, O’Connor C, Keteyian S, Landzberg J, Howlett J, et al. Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial. JAMA. 2012;308:465–74.

    PubMed  CAS  Google Scholar 

  74. Barnes PM, Schoenborn CA. Trends in adults receiving a recommendation for exercise or other physical activity from a physician or other health professional. NCHS Data Brief. 2012;86:1–8.

    PubMed  Google Scholar 

  75. Moyad MA. Dr Moyad’s no Bogus science health advice. Ann Arbor, MI: Ann Arbor Media Group; 2009.

    Google Scholar 

  76. Yu JN, Cunningham JA, Rosenberg Thouin S, Gurvich T, Liu D. Hyperlipidemia. Prim Care. 2000;27:541–87.

    PubMed  CAS  Google Scholar 

  77. Ornish D, Weidner G, Fair WR, Marlin R, Pettengill EB, Raisin CJ, et al. Intensive lifestyle changes may affect the progression of prostate cancer. J Urol. 2005;174:1065–9.

    PubMed  Google Scholar 

  78. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr. 2010;91:535–46.

    PubMed  CAS  Google Scholar 

  79. Yamagishi K, Iso H, Yatsuya H, Tanabe N, Date C, Kikuchi S, JACC Study Group, et al. Dietary intake of saturated fatty acids and mortality from cardiovascular disease in Japanese: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC) Study. Am J Clin Nutr. 2010;92:759–65.

    PubMed  CAS  Google Scholar 

  80. Mozaffarian D, Micha R, Wallace S. Effects of coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7:e1000252.

    PubMed  Google Scholar 

  81. Chiuve SE, Rimm EB, Sandhu RK, Bernstein AM, Rexrode KM, Manson JE, et al. Dietary fat quality and risk of sudden cardiac death in women. Am J Clin Nutr. 2012;96:498–507.

    PubMed  CAS  Google Scholar 

  82. Giovannucci E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst. 1999;91:317–31.

    PubMed  CAS  Google Scholar 

  83. Moyad MA. The ABCs of nutrition and supplements for prostate cancer. Ann Arbor, MI: JW Edwards; 2000.

    Google Scholar 

  84. http://www.usda.gov. Accessed 25 Oct 2010.

  85. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev. 1998;56:35–51.

    PubMed  CAS  Google Scholar 

  86. Mourvaki E, Gizzi S, Rossi R, Rufini S. Passionflower fruit-a “new” source of lycopene? J Med Food. 2005;8:104–6.

    PubMed  CAS  Google Scholar 

  87. Ilic D, Forbes KM, Hassed C. Lycopene for the prevention of prostate cancer. Cochrane Database Syst Rev. 2011;11, CD008007.

    PubMed  Google Scholar 

  88. Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas. 2012;72:269–76.

    PubMed  CAS  Google Scholar 

  89. Ried K, Fakler P. Protective effect of lycopene on serum cholesterol and blood pressure: meta-analyses of intervention trials. Maturitas. 2011;68:299–310.

    PubMed  CAS  Google Scholar 

  90. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006;12(13):4018–26.

    PubMed  CAS  Google Scholar 

  91. Forest CP, Padma-Nathan H, Liker HR. Efficacy and safety of pomegranate juice on improvement of erectile dysfunction in male patients with mild to moderate erectile dysfunction: a randomized, placebo-controlled, double-blind, cross-over study. Int J Impot Res. 2007;19:564–7.

    PubMed  CAS  Google Scholar 

  92. Uno T, Yasui-Furukori N. Effect of grapefruit juice in relation to human pharmacokinetic study. Curr Clin Pharmacol. 2006;1:157–61.

    PubMed  CAS  Google Scholar 

  93. Komperda KE. Potential interaction between pomegranate juice and warfarin. Pharmacotherapy. 2009;29:1002–6.

    PubMed  CAS  Google Scholar 

  94. Jarvis S, Li C, Bogle RG. Possible interaction between pomegranate juice and warfarin. Emerg Med J. 2010;27:74–5.

    PubMed  CAS  Google Scholar 

  95. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and prostate cancer risk. J Natl Cancer Inst. 2000;92:61–8.

    PubMed  CAS  Google Scholar 

  96. Kristal AR, Lampe JW. Brassica vegetables and prostate cancer risk: a review of the epidemiological evidence. Nutr Cancer. 2002;42:1–9.

    PubMed  Google Scholar 

  97. Hsing AW, Chokkalingam AP, Gao Y-T, Madigan MP, Deng J, Gridley G, et al. Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst. 2002;94:1648–51.

    PubMed  CAS  Google Scholar 

  98. Walker C, Reamy BV. Diets for cardiovascular disease prevention: what is the evidence? Am Fam Physician. 2009;79:571–8.

    PubMed  Google Scholar 

  99. Duthie GG, Wood AD. Natural salicylates: foods, functions and disease prevention. Food Funct. 2011;2:515–20.

    PubMed  CAS  Google Scholar 

  100. Boffetta P, Couto E, Wichmann J, Ferrari P, Trichopoulos D, Bueno-de-Mesquita HB, et al. Fruit and vegetable intake and overall cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst. 2010;102: 529–37.

    PubMed  CAS  Google Scholar 

  101. Buchner FL, Bueno-de-Mesquita HB, Ros MM, Kampman E, Egevad L, Overvad K, et al. Variety in vegetable and fruit consumption and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128:2971–9.

    PubMed  Google Scholar 

  102. Grant EJ, Ozasa K, Preston DL, Suyama A, Shimizu Y, Sakata R, et al. Effects of radiation and lifestyle factors on risks of urothelial carcinoma in the life span study of atomic bomb survivors. Radiat Res. 2012;178:86–98.

    PubMed  CAS  Google Scholar 

  103. Van Horn L. Fiber, lipids, and coronary heart disease. Nutrition Committee Advisory. Circulation. 1997;95:2701–4.

    PubMed  Google Scholar 

  104. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr. 1999;69:30–42.

    PubMed  CAS  Google Scholar 

  105. Anderson JW, Baird P, Davis Jr RH, Ferreri S, Knudtson M, Koraym A, et al. Health benefits of dietary fiber. Nutr Rev. 2009;67:188–205.

    PubMed  Google Scholar 

  106. Slavin JL. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2008;108:1716–31.

    PubMed  Google Scholar 

  107. Pereira MA, O’Reilly E, Augustsson K, Fraser GE, Goldbourt U, Heitmann BL, et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med. 2004;164:370–6.

    PubMed  Google Scholar 

  108. Pietinen P, Rimm EB, Korhonen P, Hartman AM, Willett WC, Albanes D, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men: the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation. 1996;94:2720–7.

    PubMed  CAS  Google Scholar 

  109. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996;275:447–51.

    PubMed  CAS  Google Scholar 

  110. Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med. 2011;171: 1061–8.

    PubMed  Google Scholar 

  111. Eshak ES, Iso H, Date C, Kikuchi S, Watanabe Y, Wada Y, et al. Dietary fiber intake is associated with reduced risk of mortality from cardiovascular disease among Japanese men and women. J Nutr. 2010;140:1445–53.

    PubMed  CAS  Google Scholar 

  112. Moreyra AE, Wilson AC, Koraym A. Effect of combining psyllium fiber with simvastatin in lowering cholesterol. Arch Intern Med. 2005;165:1161–6.

    PubMed  CAS  Google Scholar 

  113. Agrawal AR, Tandon M, Sharma PL. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects. Int J Clin Pract. 2007;61:1812–8.

    PubMed  CAS  Google Scholar 

  114. Streppel MT, Arends LR, van’t Veer P, Grobbee DE, Geleijnse JM. Dietary fiber and blood pressure: a meta-analysis of randomized placebo-controlled trials. Arch Intern Med. 2005;165:150–6.

    PubMed  Google Scholar 

  115. Vernay M, Aidara M, Salanave B, Deschamps V, Malon A, Oleko A, et al. Diet and blood pressure in 18–74 year old adults: the French Nutrition and Health Survey (ENNS, 2006–2007). J Hypertens. 2012;30:1920–7.

    PubMed  CAS  Google Scholar 

  116. Marlett JA, McBurney MI, Slavin JL, American Dietetic Association. Position of the American Dietetic Association: health implications of dietary fiber. J Am Diet Assoc. 2002;102:993–1000.

    PubMed  Google Scholar 

  117. Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr. 2009;90:288–97.

    PubMed  CAS  Google Scholar 

  118. Rodriguez-Leyva D, Dupasquier CM, McCullough R, Pierce GN. The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid. Can J Cardiol. 2010;26:489–96.

    PubMed  Google Scholar 

  119. Demark-Wahnefried W, Price DT, Polascik TJ, Robertson CN, Anderson EE, Paulson DF, et al. Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology. 2001;58:47–52.

    PubMed  CAS  Google Scholar 

  120. Demark-Wahnefried W, Robertson CN, Walther PJ, Polascik TJ, Paulson DF, Vollmer RT. Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen. Urology. 2004;63:900–4.

    PubMed  Google Scholar 

  121. Demark-Wahnefried W, Polascik TJ, George SL, Switzer BR, Madden JF, Ruffin 4th MT, et al. Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev. 2008;17:3577–87.

    PubMed  CAS  Google Scholar 

  122. Zhang W, Wang X, Liu Y, Tian H, Flickinger B, Empie MW, et al. Effects of dietary flaxseed lignan extract on symptoms of benign prostatic hyperplasia. J Med Food. 2008;11:207–14.

    PubMed  CAS  Google Scholar 

  123. Jin F, Nieman DC, Sha W, Xie G, Qiu Y, Jia W. Supplementation of milled chia seeds increases plasma ALA and EPA in postmenopausal women. Plant Foods Hum Nutr. 2012;67:105–10.

    PubMed  CAS  Google Scholar 

  124. Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Wilson RS, et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol. 2003;60:940–6.

    PubMed  Google Scholar 

  125. Morris MC. The role of nutrition in Alzheimer’s disease: epidemiological evidence. Eur J Neurol. 2009;16 Suppl 1:1–7.

    PubMed  Google Scholar 

  126. Moyad MA. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part I. Urol Oncol. 2005;23:28–35.

    PubMed  CAS  Google Scholar 

  127. Moyad MA. An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: Part II. Urol Oncol. 2005;23:36–48.

    PubMed  CAS  Google Scholar 

  128. Bucher HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med. 2002;112:298–304.

    PubMed  CAS  Google Scholar 

  129. Kris-Etherton PM, Harris WS, Appel LJ, Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106:2747–57.

    PubMed  Google Scholar 

  130. Harris WS. N-3 fatty acids and serum lipoproteins: human studies. Am J Clin Nutr. 1997;65(5 Suppl): 1645S–54.

    PubMed  CAS  Google Scholar 

  131. Cabo J, Alonso R, Mata P. Omega-3 fatty acids and blood pressure. Br J Nutr. 2012;107 Suppl 2:S195–200.

    PubMed  CAS  Google Scholar 

  132. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, et al. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002;346:1113–8.

    PubMed  CAS  Google Scholar 

  133. Augustsson K, Michaud DS, Rimm EB, Leitzmann MF, Stampfer MJ, Willett WC, et al. A prospective study of intake of fish and marine fatty acids and prostate cancer. Cancer Epidemiol Biomark Prev. 2003;12:64–7.

    CAS  Google Scholar 

  134. Yang YJ, Lee SH, Hong SJ, Chung BC. Comparison of fatty acid profiles in the serum of patients with prostate cancer and benign prostatic hyperplasia. Clin Biochem. 1999;32:405–9.

    PubMed  CAS  Google Scholar 

  135. Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. Am J Clin Nutr. 2010;92:1223–33.

    PubMed  CAS  Google Scholar 

  136. Siener R, Jansen B, Watzer B, Hesse A. Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone formation. J Urol. 2011;185: 719–24.

    PubMed  CAS  Google Scholar 

  137. Yasui T, Suzuki S, Itoh Y, Tozawa K, Tokudome S, Kohri K. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis. Urol Int. 2008;81:135–8.

    PubMed  CAS  Google Scholar 

  138. Guallar E, Sanz-Gallardo MI, van’t Veer P, Bode P, Aro A, Gomez-Aracena J, et al. Mercury, fish oils, and the risk of myocardial infarction. N Engl J Med. 2002;347:1747–54.

    PubMed  CAS  Google Scholar 

  139. Yoshizawa K, Rimm EB, Morris JS, Spate VL, Hsieh CC, Spiegelman D, et al. Mercury and the risk of coronary heart disease in men. N Engl J Med. 2002;347:1755–60.

    PubMed  CAS  Google Scholar 

  140. Virtanen JK, Laukkanen JA, Mursu J, Voutilainen S, Tuomainen TP. Serum long-chain n-3 polyunsaturated fatty acids, mercury, and risk of sudden cardiac death in men: a prospective population-based study. PLoS One. 2012;7:e41046.

    PubMed  CAS  Google Scholar 

  141. Weil M, Bressler J, Parsons P, Bolla K, Glass T, Schwartz B. Blood mercury levels and neurobehavioral function. JAMA. 2005;293:1875–82.

    PubMed  CAS  Google Scholar 

  142. DeRouen TA, Martin MD, Leroux BG, Townes BD, Woods JS, Leitao J, et al. Neurobehavioral effects of dental amalgam in children: a randomized clinical trial. JAMA. 2006;295:1784–92.

    PubMed  CAS  Google Scholar 

  143. Mozaffarian D, Shi P, Morris JS, Spiegelman D, Grandjean P, Siscovick DS, et al. Mercury exposure and risk of cardiovascular disease in two U.S. cohorts. N Engl J Med. 2011;364:1116–25.

    PubMed  CAS  Google Scholar 

  144. Kris-Etherton PM, Harris WS, Appel LJ, AHA Nutrition Committee, American Heart Association. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler Thromb Vasc Biol. 2003;23:151–2.

    PubMed  CAS  Google Scholar 

  145. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results from the GISSI-Prevenzione trial. Lancet. 1999;354:447–55.

    Google Scholar 

  146. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, et al. Early protection against sudden cardiac death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002;105:1897–903.

    PubMed  CAS  Google Scholar 

  147. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet. 2007;369:1090–8.

    PubMed  CAS  Google Scholar 

  148. Kwak SM, Myung SK, Lee YJ, Seo HG, Korean Meta-Analysis Study Group, et al. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. Arch Intern Med. 2012;172:686–94.

    PubMed  CAS  Google Scholar 

  149. O’Neil CE, Keast DR, Nicklas TA, Fulgoni 3rd VL. Nut consumption is associated with decreased health risk factors for cardiovascular disease and metabolic syndrome in U.S. adults: NHANES 1999–2004. J Am Coll Nutr. 2011;30:502–10.

    PubMed  Google Scholar 

  150. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the physicians’ health study. Arch Intern Med. 2002;162:1382–7.

    PubMed  Google Scholar 

  151. Ellsworth JL, Kushi LH, Folsom AR. Frequent nut intake and risk of death from coronary heart disease and all causes in postmenopausal women: the Iowa Women’s Health Study. Nutr Metab Cardiovasc Dis. 2001;11:372–7.

    PubMed  CAS  Google Scholar 

  152. Fraser GE, Shavlik DJ. Risk factors for all-cause and coronary heart disease mortality in the oldest-old: the Adventist Health Study. Arch Intern Med. 1997;157:2249–58.

    PubMed  CAS  Google Scholar 

  153. Sabate J, Wien M. Nuts, blood lipids and cardiovascular disease. Asia Pac J Clin Nutr. 2010;19:131–6.

    PubMed  CAS  Google Scholar 

  154. Casas-Agustench P, Bullo M, Salas-Salvado J. Nuts, inflammation and insulin resistance. Asia Pac J Clin Nutr. 2010;19:124–30.

    PubMed  CAS  Google Scholar 

  155. Aldemir M, Okulu E, Neselioglu S, Erel KO. Pistachio diet improves erectile function parameters and serum lipid profiles in patients with erectile dysfunction. Int J Impot Res. 2011;23:32–8.

    PubMed  CAS  Google Scholar 

  156. Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307:1273–83.

    PubMed  CAS  Google Scholar 

  157. Hu FB, Willett WC, Tricia L, Stampfer MJ, Colditz GA, Manson JE. Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 2004;351(26):2694–703.

    PubMed  CAS  Google Scholar 

  158. Ajani UA, Lotufo PA, Gaziano JM, Lee IM, Spelsberg A, Buring JE, et al. Body mass index and mortality among US male physicians. Ann Epidemiol. 2004;14:731–9.

    PubMed  Google Scholar 

  159. Baik I, Ascherio A, Rimm EB, Giovannucci E, Spiegelman D, Stampfer MJ, et al. Adiposity and mortality in men. Am J Epidemiol. 2000;152:264–71.

    PubMed  CAS  Google Scholar 

  160. Platz EA, Willet WC, Colditz GA, Rimm EB, Spiegelman D, Giovannucci E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control. 2000;11:579–88.

    PubMed  CAS  Google Scholar 

  161. Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a mediterranean diet and survival in a Greek population. N Engl J Med. 2003;348: 2599–608.

    PubMed  Google Scholar 

  162. Mitrou PN, Kipnis V, Thiebaut AC, Reedy J, Subar AF, Wirfalt E, et al. Mediterranean dietary pattern and prediction of all-cause mortality in a U.S. population: results from the NIH-AARP Diet and Health Study. Arch Int Med. 2007;167:2461–8.

    Google Scholar 

  163. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, on behalf of the INTERHEART Study Investigators, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.

    PubMed  Google Scholar 

  164. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA. 2007;297:286–94.

    PubMed  CAS  Google Scholar 

  165. Wilcox BJ, He Q, Chen R, Yano K, Masaki KH, Grove JS, et al. Midlife risk factors and healthy survival in men. JAMA. 2006;296:2343–50.

    Google Scholar 

  166. Yates LB, Djousse L, Kurth T, Buring JE, Gaziano JM. Exceptional longevity in men: modifiable factors associated with survival and function to age 90 years. Arch Int Med. 2008;168:284–90.

    Google Scholar 

  167. Terry DF, Pencina MJ, Vasan RS, Murabito JM, Wolf PA, Hayes MK, et al. Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants. J Am Geriatr Soc. 2005;53:1944–50.

    PubMed  Google Scholar 

  168. Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F, et al. Effect of lifestyle changes on erectile dysfunction in obese men. JAMA. 2004;291(24):2978–84.

    PubMed  CAS  Google Scholar 

  169. Giugliano D, Giugliano F, Esposito K. Sexual dysfunction and the Mediterranean diet. Public Health Nutr. 2006;9:1118–20.

    PubMed  Google Scholar 

  170. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA. 2003;290:86–97.

    PubMed  Google Scholar 

  171. Ehdale B, Furberg H, Zabor EC, Ostroff JS, Shariat SF, Bochner BH, et al. Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma. BJU Int. 2012;111:589–95.

    Google Scholar 

  172. Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomarkers Prev. 2003;12:604–9.

    PubMed  CAS  Google Scholar 

  173. Roberts WW, Platz EA, Walsh PC. Association of cigarette smoking with extraprostatic prostate cancer in young men. J Urol. 2003;169:512–6.

    PubMed  Google Scholar 

  174. Rodriguez C, Tatham LM, Thun MJ, Calle EE, Heath Jr CW. Smoking and fatal prostate cancer in a large cohort of adult men. Am J Epidemiol. 1997;145:466–75.

    PubMed  CAS  Google Scholar 

  175. Bassett JC, Gore JL, Chi AC, Kwan L, McCarthy W, Chamie K, et al. Impact of bladder cancer diagnosis on smoking behavior. J Clin Oncol. 2012;30:1871–8.

    PubMed  Google Scholar 

  176. Mukamal KJ, Conigrave KM, Mittleman MA, Camargo Jr CA, Stampfer MJ, Willett WC, et al. Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med. 2003;348:109–18.

    PubMed  Google Scholar 

  177. Pai JK, Mukamal KJ, Rimm EB. Long-term alcohol consumption in relation to all-cause and cardiovascular mortality among survivors of myocardial infarction: the Health Professionals Follow-up Study. Eur Heart J. 2012;33:1598–605.

    PubMed  CAS  Google Scholar 

  178. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117–24.

    PubMed  CAS  Google Scholar 

  179. Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10.

    PubMed  CAS  Google Scholar 

  180. Karanja N, Erlinger TP, Pao-Hwa L, Miller ER, Bray GA. The DASH diet for high blood pressure: from clinical trial to dinner table. Cleve Clin J Med. 2004;71(9):745–53.

    PubMed  Google Scholar 

  181. Taylor EN, Fung TT, Curhan GC. DASH-Style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20:2253–9.

    PubMed  CAS  Google Scholar 

  182. Rock CL. Multivitamin–multimineral supplements: who uses them? Am J Clin Nutr. 2007;85(suppl):277S–9.

    PubMed  CAS  Google Scholar 

  183. Gahche J, Bailey R, Burt V, Hughes J, Yetley E, Dwyer J, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988–1994). NCHS Data Brief 2011;(61):1–8.

    Google Scholar 

  184. Barqawi A, Gamito E, O’Donnell C, Crawford ED. Herbal and vitamin supplement use in a prostate cancer screening population. Urology. 2004;63:288–92.

    PubMed  Google Scholar 

  185. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol. 2008;167:925–34.

    PubMed  Google Scholar 

  186. Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano M. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med. 2002;162:1472–6.

    PubMed  Google Scholar 

  187. Shikany JM, Patterson RE, Agurs-Collins T, Anderson G. Antioxidant supplement use in Women’s Health Initiative participants. Prev Med. 2003;36:379–87.

    PubMed  Google Scholar 

  188. Neuhouser ML, Wassertheil-Smoller S, Thomson C, Aragaki A, Anderson GL, Manson JE, et al. Multivitamin use and risk of cancer and cardiovascular disease in the Women’s Health Initiative cohorts. Arch Intern Med. 2009;169:294–304.

    PubMed  Google Scholar 

  189. Giovannucci E, Chan AT. Role of vitamin and mineral supplementation and aspirin use in cancer survivors. J Clin Oncol. 2010;28:4081–5.

    PubMed  CAS  Google Scholar 

  190. Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, et al. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. J Natl Cancer Inst. 2007;99:754–64.

    PubMed  CAS  Google Scholar 

  191. Stevens VL, McCullough ML, Diver WR, Rodriguez C, Jacobs EJ, Thun MJ, et al. Use of multivitamins and prostate cancer mortality in a large cohort of US men. Cancer Causes Control. 2005;16:643–50.

    PubMed  Google Scholar 

  192. Neuhouser ML, Barnett MJ, Kristal AR, Ambrosone CB, King IB, Thornquist M, et al. Dietary supplement use and prostate cancer risk in the Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prev. 2009;18:2202–6.

    PubMed  CAS  Google Scholar 

  193. Larsson SC, Akesson A, Bergkvist L, Wolk A. Multivitamin use and breast cancer incidence in a prospective cohort of Swedish women. Am J Clin Nutr. 2010;91:1268–72.

    PubMed  CAS  Google Scholar 

  194. Berube S, Diorio C, Brisson J. Multivitamin-multimineral supplement use and mammographic breast density. Am J Clin Nutr. 2008;87:1400–4.

    PubMed  CAS  Google Scholar 

  195. Clarke R, Halsey J, Lewington S, Lonn E, Armitage J, Manson JE, et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality. Arch Intern Med. 2010;170:1622–31.

    PubMed  CAS  Google Scholar 

  196. Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD, et al. Circulating folate, vitamin B12, homocysteine, vitamin B12 transport proteins, and risk of prostate cancer: a case–control study, systematic review, and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:1632–42.

    PubMed  CAS  Google Scholar 

  197. Ng K, Meyerhardt JA, Chan JA, Niedzwiecki D, Hollis DR, Saltz LB, et al. Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2010;28:4354–63.

    PubMed  Google Scholar 

  198. Li Q, Chuang SC, Eluf-Neto J, Menezes A, Matos E, Koifman S, et al. Vitamin or mineral supplement intake and the risk of head and neck cancer: pooled analysis in the INHANCE consortium. Int J Cancer. 2012;131:1686–99.

    PubMed  CAS  Google Scholar 

  199. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164:2335–42.

    PubMed  CAS  Google Scholar 

  200. Meyer F, Galan P, Douville P, Bairati I, Kegle P, Bertrais S, et al. Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer. 2005;116:182–6.

    PubMed  CAS  Google Scholar 

  201. Klein EA, Thompson Jr IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E cancer prevention trial (SELECT). JAMA. 2011;306: 1549–56.

    PubMed  CAS  Google Scholar 

  202. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial. JAMA. 2008;300:2123–33.

    PubMed  CAS  Google Scholar 

  203. Christen WG, Gaziano JM, Hennekens CH. Design of Physicians’ Health Study II-a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials. Ann Epidemiol. 2000;10:125–34.

    PubMed  CAS  Google Scholar 

  204. Barnett CM, Beer TM. Prostate cancer and vitamin D: what does the evidence really suggest? Urol Clin North Am. 2011;38:333–42.

    PubMed  Google Scholar 

  205. Isenor JE, Ensom MH. Is there a role for therapeutic drug monitoring of vitamin D level as a surrogate marker for fracture risk. Pharmacotherapy. 2010;30: 254–64.

    PubMed  CAS  Google Scholar 

  206. Smith MR, Egerdie B, HernandezToriz N, Feldman R, Tammela TL, Saad F, Denosumab HALT Prostate Cancer Study Group, et al. N Engl J Med. 2009;361:745–55.

    PubMed  CAS  Google Scholar 

  207. Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010;92:841–8.

    PubMed  CAS  Google Scholar 

  208. Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, et al. Annual high-dose oral vitamin D and falls and fractures in older women. JAMA. 2010;303:1815–22.

    PubMed  CAS  Google Scholar 

  209. Rothwell PM, Fowkes FG, Belch JK, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomized trials. Lancet. 2011;377:31–41.

    PubMed  CAS  Google Scholar 

  210. Jalving M, Gietema JA, Lefrandt JD, de Jong S, Reyners AK, Gans RO, et al. Metformin: taking away the candy for cancer? Eur J Cancer. 2010;46: 2369–80.

    PubMed  CAS  Google Scholar 

  211. Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet. 2009;374:1677–86.

    Google Scholar 

  212. Platz EA, Till C, Goodman PJ, Parnes HL, Figg WD, Albanes D, et al. Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev. 2009;18: 2807–13.

    PubMed  CAS  Google Scholar 

  213. Murtola TJ, Visakorpi T, Lahtela J, Syvala H, Tammela TL. Statins and prostate cancer prevention: where we are now and future directions. Nat Clin Pract Urol. 2008;5:376–87.

    PubMed  CAS  Google Scholar 

  214. St Sauver JL, Jacobsen SJ, Jacobson DJ, McGree ME, Girman CJ, Nehra A. Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms. BJU Int. 2011;107:443–50.

    PubMed  Google Scholar 

  215. Dadkhah F, Safarinejad MR, Asgari MA, Hosseini SY, Lashay A, Amini E. Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction and not initially responsive to sildenafil. Int J Impot Res. 2010;22:51–60.

    PubMed  CAS  Google Scholar 

  216. Solomon KR, Freeman MR. The complex interplay between cholesterol and prostate malignancy. Urol Clin N Am. 2011;38:243–59.

    Google Scholar 

  217. Moyad MA. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part I. Urol Oncol. 2004;22:466–71.

    PubMed  CAS  Google Scholar 

  218. Moyad MA. Why a statin and/or another proven heart healthy agent should be utilized in the next major cancer chemoprevention trial: part II. Urol Oncol. 2004;22:472–7.

    PubMed  CAS  Google Scholar 

  219. Moyad MA. Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part I. Curr Opin Urol. 2005;15:1–6.

    PubMed  Google Scholar 

  220. Moyad MA. Heart healthy equals prostate healthy equals statins: the next cancer chemoprevention trial. Part II. Curr Opin Urol. 2005;15:7–12.

    PubMed  Google Scholar 

  221. De Berardis G, Lucisano G, D’Ettorre A, Pellegrini F, Lepore V, Tognoni G, et al. Association of aspirin use with major bleeding in patients with and without diabetes. JAMA. 2012;307:2286–94.

    PubMed  Google Scholar 

  222. Dell’Aglio DM, Perino LJ, Kazzi Z, Abramson J, Schwartz MD, Morgan BW. Acute metformin overdose: examining pH, lactate level, and metformin concentrations in survivors versus nonsurvivors: a systematic review of the literature. Ann Emerg Med. 2009;54:818–23.

    PubMed  Google Scholar 

  223. Zaharan NL, Williams D, Bennett K. Statins and risk of treated incident diabetes in a primary care population. Br J Clin Pharmacol. 2013;75:1118–24.

    PubMed  CAS  Google Scholar 

  224. American Urological Association. Guidelines at a glance: a quick reference for Urologists-2012. Linthicum, MD: American Urological Association; 2012.

    Google Scholar 

  225. Montague DK, Jarow JP, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Erectile Dysfunction Guideline Update Panel, et al. Chapter 1: The management of erectile dysfunction: an AUA update. J Urol. 2005;174:230–9.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, University of Michigan Medical Center, Ann Arbor, MI, USA

    Mark A. Moyad M.D., M.P.H.

Authors
  1. Mark A. Moyad M.D., M.P.H.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Moyad, M.A. (2014). The Ideal Eight-Step Urologic Diet and Lifestyle Program: Heart Health = Urologic Health. In: Complementary & Alternative Medicine for Prostate and Urologic Health. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8492-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8492-9_1

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8491-2

  • Online ISBN: 978-1-4614-8492-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation